Table of Content
Executive Summary
Chapter 1 – Introduction
Chapter 2 – Trends in antibody dealmaking
2.1. Introduction
2.2. Antibody deals over the years
2.3. Most active antibody dealmakers
2.4. Antibody deals by deal type
2.5. Antibody deals by therapy area
2.6. Antibody deals by industry sector
2.7. Deal terms for antibody deals
2.7.1 Antibody deals headline values
2.7.2 Antibody deal upfront payments
2.7.3 Antibody deal milestone payments
2.7.4 Antibody royalty rates
Chapter 3 – Leading antibody deals
3.1. Introduction
3.2. Top antibody deals by value
Chapter 4 – Most active antibody dealmakers
4.1. Introduction
4.2. Most active antibody dealmakers
4.3. Most active antibody deals company profiles
Chapter 5 – Antibody contracts dealmaking directory
5.1. Introduction
5.2. Antibody contracts dealmaking directory
Chapter 6 – Antibody dealmaking by technology type
Deal directory
Deal directory – Antibody deals by company A-Z
Deal directory – Antibody deals by deal type
Deal directory – Antibody deals by therapy area
Deal type definitions
About Wildwood Ventures
Current Partnering
Current Agreements
Recent report titles from Current Partnering
?
Table of figures
Figure 1: Antibody deals since 2016
Figure 2: Active antibody dealmaking activity – 2016 - 2023
Figure 3: Antibody deals by deal type since 2016
Figure 4: Antibody deals by therapy area since 2016
Figure 5: Antibody deals by industry sector since 2016
Figure 6: Antibody deals with a headline value
Figure 7: Antibody deals with an upfront value
Figure 8: Antibody deals with a milestone value
Figure 9: Antibody deals with a royalty rate value
Figure 10: Top antibody deals by value since 2016
Figure 11: Most active antibody dealmakers 2016 - 2023
Figure 12: Antibody deals by technology type since 2016